Use of diuretic agents in obese or black patients with systemic hypertension.

Any increase in arterial pressure is the result of either an increase in cardiac output, an increase in total peripheral resistance or a combination of the two. Hypertension is not a homogeneous disease, however, and different mechanisms may be operative during the life span of the patient. Hypertension in the young, nonobese patient is usually hemodynamically characterized by high cardiac output, normal to slightly contracted intravascular volume and numerically normal total peripheral resistance. In contrast, hypertension in the middle-aged or elderly patient is usually hemodynamically characterized by normal to low cardiac output, contracted intravascular volume and high total peripheral resistance. Two further subgroups of hypertensive patients can be identified: obese patients, whose hypertension is characterized by high cardiac output, expanded intravascular volume and normal or low total peripheral resistance, and black patients, whose hemodynamic and fluid volume findings are similar to those of their white counterparts, but who tend to have lower heart rates and greater responsiveness to intravascular volume depletion than white hypertensive subjects. A rational therapeutic approach to essential hypertension should take into account these variable pathophysiologic features. Thiazide diuretics continue to be appropriate and generally well-tolerated choices for initial antihypertensive therapy in obese or in black patients. Many obese patients or black patients, however, are likely to develop early left ventricular (LV) hypertrophy.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Stamler,et al.  Weight and blood pressure. Findings in hypertension screening of 1 million Americans. , 1978, JAMA.

[2]  R. Holle,et al.  Renal vasculature in essential hypertension: racial differences. , 1978, Annals of internal medicine.

[3]  J. V. Nixon,et al.  Diuretic-induced ventricular ectopic activity. , 1981, The American journal of medicine.

[4]  B. Materson,et al.  Potassium and diuretic-induced ventricular arrhythmias in ambulatory hypertensive patients. , 1984, Mineral and electrolyte metabolism.

[5]  Sjögren Al,et al.  Left Ventricular Wall Thickness Determined by Ultrasound in 100 Subjects without Heart Disease , 1971 .

[6]  C. Davidson,et al.  Hypokalaemia and diuretics: an analysis of publications. , 1980, British medical journal.

[7]  J. Hollifield Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. , 1984, The American journal of medicine.

[8]  E. Freis Hemodynamics of hypertension. , 1960, Physiological reviews.

[9]  S. Julius,et al.  Relationship Between Cardiac Output and Peripheral Resistance in Borderline Hypertension , 1971, Circulation.

[10]  F. Dunn,et al.  Dimorphic cardiac adaptation to obesity and arterial hypertension. , 1983, Annals of internal medicine.

[11]  F. Dunn,et al.  Clinical and hemodynamic determinants of left ventricular dimensions. , 1984, Archives of internal medicine.

[12]  F. Messerli,et al.  Systemic and Regional Hemodynamics in Low, Normal and High Cardiac Output Borderline Hypertension , 1978, Circulation.

[13]  S. Julius,et al.  Mild high-renin essential hypertension. Neurogenic human hypertension? , 1977, The New England journal of medicine.

[14]  W. Kannel,et al.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. , 1969, Annals of internal medicine.

[15]  R. Tarazi,et al.  Hypertension in Obese Patients: Hemodynamic and Volume Studies , 1982, Hypertension.

[16]  W. Kannel,et al.  Obesity and cardiovascular disease: The Framingham study , 1976 .

[17]  E. Frohlich,et al.  II. HEMODYNAMIC ASPECTS OF HYPERTENSION: Physiological Comparison of Labile and Essential Hypertension , 1970, Circulation research.

[18]  F. Messerli,et al.  Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. , 1981, Archives of internal medicine.

[19]  J. Hodler,et al.  Changes in renal function in essential hypertension. , 1978, The American journal of medicine.

[20]  E. Lakatta,et al.  Age changes in myocardial function and exercise response. , 1976, Progress in cardiovascular diseases.

[21]  F. Messerli,et al.  ESSENTIAL HYPERTENSION IN THE ELDERLY: HAEMODYNAMICS, INTRAVASCULAR VOLUME, PLASMA RENIN ACTIVITY, AND CIRCULATING CATECHOLAMINE LEVELS , 1983, The Lancet.

[22]  F. Dunn,et al.  Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. , 1984, Mineral and electrolyte metabolism.

[23]  J. Widimský,et al.  Changes of cardiac output in hypertensive disease. , 1957, Cardiologia.

[24]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[25]  M. Weber,et al.  Low‐dose diuretic and beta adrenoceptor blocker in essential hypertension , 1980, Clinical pharmacology and therapeutics.

[26]  D. Adams,et al.  Senescence and the Renal Vasculature in Normal Man , 1974, Circulation research.

[27]  C. Gomez-Sanchez,et al.  Antihypertensive Comparison of Furosemide with Hydrochlorothiazide for Black Patients , 1979 .

[28]  F. Messerli,et al.  Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state. , 1979, The American journal of medicine.

[29]  J. Hollifield,et al.  Thiazide diuretics, hypokalemia and cardiac arrhythmias. , 2009, Acta medica Scandinavica. Supplementum.

[30]  Alexander Jk Obesity and circulation. , 1963 .

[31]  A. Keys,et al.  Drastic food restriction; effect on cardiovascular dynamics in normotensive and hypertensive conditions. , 1948, Journal of the American Medical Association.

[32]  F. Dunn,et al.  Racial differences in cardiac adaptation to essential hypertension determined by echocardiography indexes , 1983 .

[33]  F. Messerli,et al.  Diuretics as Antihypertensive Agents , 1982 .